共 16 条
- [1] Anti-Factor-Xa and Activated Partial Thromboplastin Time Concordance and Outcomes in Adults Undergoing Extracorporeal Membrane Oxygenation: A Secondary Analysis of the Pilot Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation Randomized Trial [J]. CRITICAL CARE EXPLORATIONS, 2023, 5 (11) : E0999
- [9] Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 1999, 21 (01): : 55 - 60
- [10] Olson JD, 1998, ARCH PATHOL LAB MED, V122, P782